These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1807 related items for PubMed ID: 19095124

  • 1. Evaluating localized prostate cancer and identifying candidates for focal therapy.
    Sartor AO, Hricak H, Wheeler TM, Coleman J, Penson DF, Carroll PR, Rubin MA, Scardino PT.
    Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
    [Abstract] [Full Text] [Related]

  • 2. Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities.
    Eggener SE, Scardino PT, Carroll PR, Zelefsky MJ, Sartor O, Hricak H, Wheeler TM, Fine SW, Trachtenberg J, Rubin MA, Ohori M, Kuroiwa K, Rossignol M, Abenhaim L, International Task Force on Prostate Cancer and the Focal Lesion Paradigm.
    J Urol; 2007 Dec; 178(6):2260-7. PubMed ID: 17936815
    [Abstract] [Full Text] [Related]

  • 3. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
    Gallina A, Maccagnano C, Suardi N, Capitanio U, Abdollah F, Raber M, Salonia A, Scattoni V, Rigatti P, Montorsi F, Briganti A.
    BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108
    [Abstract] [Full Text] [Related]

  • 4. Prostate biopsy: who, how and when. An update.
    Djavan B, Milani S, Remzi M.
    Can J Urol; 2005 Feb; 12 Suppl 1():44-8; discussion 99-100. PubMed ID: 15780165
    [Abstract] [Full Text] [Related]

  • 5. Conventional treatments of localized prostate cancer.
    Zerbib M, Zelefsky MJ, Higano CS, Carroll PR.
    Urology; 2008 Dec; 72(6 Suppl):S25-35. PubMed ID: 19095125
    [Abstract] [Full Text] [Related]

  • 6. New treatments for localized prostate cancer.
    Marberger M, Carroll PR, Zelefsky MJ, Coleman JA, Hricak H, Scardino PT, Abenhaim LL.
    Urology; 2008 Dec; 72(6 Suppl):S36-43. PubMed ID: 19095127
    [Abstract] [Full Text] [Related]

  • 7. "Male lumpectomy": focal therapy for prostate cancer using cryoablation.
    Onik G, Vaughan D, Lotenfoe R, Dineen M, Brady J.
    Urology; 2007 Dec; 70(6 Suppl):16-21. PubMed ID: 18194706
    [Abstract] [Full Text] [Related]

  • 8. Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer?
    Tareen B, Godoy G, Sankin A, Temkin S, Lepor H, Taneja SS.
    BJU Int; 2009 Jul; 104(2):195-9. PubMed ID: 19191784
    [Abstract] [Full Text] [Related]

  • 9. Appropriate patient selection in the focal treatment of prostate cancer: the role of transperineal 3-dimensional pathologic mapping of the prostate--a 4-year experience.
    Barzell WE, Melamed MR.
    Urology; 2007 Dec; 70(6 Suppl):27-35. PubMed ID: 18194708
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Adenocarcinoma of the prostate].
    Dvorácek J.
    Cas Lek Cesk; 1998 Aug 31; 137(17):515-21. PubMed ID: 9787503
    [Abstract] [Full Text] [Related]

  • 12. Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer.
    Capitanio U, Karakiewicz PI, Valiquette L, Perrotte P, Jeldres C, Briganti A, Gallina A, Suardi N, Cestari A, Guazzoni G, Salonia A, Montorsi F.
    Urology; 2009 May 31; 73(5):1087-91. PubMed ID: 19195695
    [Abstract] [Full Text] [Related]

  • 13. A nomogram for predicting low-volume/low-grade prostate cancer: a tool in selecting patients for active surveillance.
    Nakanishi H, Wang X, Ochiai A, Trpkov K, Yilmaz A, Donnelly JB, Davis JW, Troncoso P, Babaian RJ.
    Cancer; 2007 Dec 01; 110(11):2441-7. PubMed ID: 17932909
    [Abstract] [Full Text] [Related]

  • 14. Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care.
    Epstein JI, Herawi M.
    J Urol; 2006 Mar 01; 175(3 Pt 1):820-34. PubMed ID: 16469560
    [Abstract] [Full Text] [Related]

  • 15. Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade.
    Tan N, Lane BR, Li J, Moussa AS, Soriano M, Jones JS.
    J Urol; 2008 Oct 01; 180(4):1325-9; discussion 1329. PubMed ID: 18707706
    [Abstract] [Full Text] [Related]

  • 16. Staging of incidentally detected prostate cancer: role of repeat resection, prostate-specific antigen, needle biopsy, and imaging.
    Griebling TL, Williams RD.
    Semin Urol Oncol; 1996 Aug 01; 14(3):156-64. PubMed ID: 8865478
    [Abstract] [Full Text] [Related]

  • 17. Imaging low-risk prostate cancer.
    Shukla-Dave A, Hricak H, Scardino PT.
    Curr Opin Urol; 2008 Jan 01; 18(1):78-86. PubMed ID: 18090495
    [Abstract] [Full Text] [Related]

  • 18. What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database.
    Barocas DA, Cowan JE, Smith JA, Carroll PR, CaPSURE Investigators.
    J Urol; 2008 Oct 01; 180(4):1330-4; discussion 1334-5. PubMed ID: 18707731
    [Abstract] [Full Text] [Related]

  • 19. Staging saturation biopsy in patients with prostate cancer on active surveillance protocol.
    Abouassaly R, Lane BR, Jones JS.
    Urology; 2008 Apr 01; 71(4):573-7. PubMed ID: 18387385
    [Abstract] [Full Text] [Related]

  • 20. [Diagnosis based on prostate needle biopsy: inadequate correlation between pathologic results and clinical course for individual prognosis].
    van der Kwast TH, Hoedemaeker RF, Schröder FH.
    Ned Tijdschr Geneeskd; 2005 Apr 30; 149(18):972-6. PubMed ID: 15903037
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 91.